BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mone P, Varzideh F, Jankauskas SS, Pansini A, Lombardi A, Frullone S, Santulli G. SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients. Hypertension 2022;79:1633-43. [PMID: 35703100 DOI: 10.1161/HYPERTENSIONAHA.122.19586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Jin X, Li D, Lu J, Zhang X, Yang S, Zhao Y, Wu M. New insights into vascular aging: Emerging role of mitochondria function. Biomedicine & Pharmacotherapy 2022;156:113954. [DOI: 10.1016/j.biopha.2022.113954] [Reference Citation Analysis]
2 Trimarco V, Izzo R, Mone P, Lembo M, Manzi MV, Pacella D, Falco A, Gallo P, Esposito G, Morisco C, Santulli G, Trimarco B. Therapeutic concordance improves blood pressure control in patients with resistant hypertension. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106557] [Reference Citation Analysis]
3 Tran P, Long T, Smith J, Kuehl M, Mahdy T, Banerjee P. Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model. Open Heart 2022;9:e002101. [DOI: 10.1136/openhrt-2022-002101] [Reference Citation Analysis]
4 Trimarco V, Izzo R, Morisco C, Mone P, Virginia Manzi M, Falco A, Pacella D, Gallo P, Lembo M, Santulli G, Trimarco B. High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients. Hypertension 2022;79:2355-63. [PMID: 35968698 DOI: 10.1161/HYPERTENSIONAHA.122.19912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Santulli G, Frullone S, Morgante M, Macina G, Pansini A, Gambardella J, Lombardi A, Mone P. Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251. Diabetes Care 2022;45:e151-2. [PMID: 36150055 DOI: 10.2337/dci22-0025] [Reference Citation Analysis]
6 Gonçalves RSDSA, Maciel ÁCC, Rolland Y, Vellas B, de Souto Barreto P. Frailty biomarkers under the perspective of geroscience: A narrative review. Ageing Res Rev 2022;81:101737. [PMID: 36162706 DOI: 10.1016/j.arr.2022.101737] [Reference Citation Analysis]
7 Zhu Y, Zhang J, Yan X, Sun L, Ji Y, Wang F. Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol 2022;21. [DOI: 10.1186/s12933-022-01627-0] [Reference Citation Analysis]
8 Gliozzi M, Macrì R, Coppoletta AR, Musolino V, Carresi C, Scicchitano M, Bosco F, Guarnieri L, Cardamone A, Ruga S, Scarano F, Nucera S, Mollace R, Bava I, Caminiti R, Serra M, Maiuolo J, Palma E, Mollace V. From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts. Nutrients 2022;14:3737. [PMID: 36145112 DOI: 10.3390/nu14183737] [Reference Citation Analysis]
9 Kansakar U, Gambardella J, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Matarese A, Santulli G. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections. IJMS 2022;23:10242. [DOI: 10.3390/ijms231810242] [Reference Citation Analysis]
10 Deng R, Jiang K, Chen F, Miao Y, Lu Y, Su F, Liang J, Qian J, Wang D, Xiang Y, Shen L. Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia. Biomed Pharmacother 2022;154:113606. [PMID: 36030589 DOI: 10.1016/j.biopha.2022.113606] [Reference Citation Analysis]
11 Tian Z, Li K, Fan D, Gao X, Ma X, Zhao Y, Zhao D, Liang Y, Ji Q, Chen Y, Yang Y. Water-Soluble Tomato Concentrate, a Potential Antioxidant Supplement, Can Attenuate Platelet Apoptosis and Oxidative Stress in Healthy Middle-Aged and Elderly Adults: A Randomized, Double-Blinded, Crossover Clinical Trial. Nutrients 2022;14:3374. [DOI: 10.3390/nu14163374] [Reference Citation Analysis]
12 Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P. SGLT2-inhibitors are effective and safe in the elderly: The SOLD study. Pharmacol Res 2022;183:106396. [PMID: 35970329 DOI: 10.1016/j.phrs.2022.106396] [Reference Citation Analysis]